The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.
The Food and Drug Administration recently expanded approval for Spravato, an antidepressant nasal spray used to treat ...
Confusion between approved injectable epinephrine products and unapproved nasal solutions has prompted a warning to ...
Green Matters on MSN2d
Viral Video Reveals the Right Way to Use Flonase, Because Apparently We're All Doing It WrongA doctor explains how to correctly use Flonase nasal spray, which includes manually opening your sinuses before you spray.
Inquirer on MSN3d
World’s first anti-depression nasal spray receives FDA approvalThe US Food and Drug Administration (FDA) approved the first-ever anti-depression nasal spray, Spravato. The pharmaceutical company Johnson & Johnson created the spray from esketamine, a more potent ...
In a Phase IIb trial, GH001 elicited significant drops in treatment-resistant depression. The news comes less than two weeks ...
Total symptom scores, nasal obstruction, and doctor and patient perception of improvement were measured as markers of disease severity. Results: Although not statistically significant, both ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback